An article in the March 2004 ED Management implied that rapid administration of tissue plasminogen activator (TPA) is the standard of care for stroke patients, when in fact it is not.

There have been lawsuits against those who used TPA and experienced a complication as well as those who did not use TPA.

The source quoted in the article primarily was addressing strategies for avoiding malpractice claims in the ED, and her personal opinion is that proper use of TPA can improve patient care and reduce liability risks.